Skip to content

MOLN

Molecular Partners AG

NASDAQ · Healthcare · Biotechnology · CH

$3.20
+3.40%
Ask drillr

Margins

Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-107.0%
Return on equity
-84.0%
Return on assets
-102.8%
Return on invested capital
0.00x
Asset turnover
-$60.2M
Cash from operations
$1.83
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026